絞り込み

16603

広告

キンギョの「設計図」解読 (デイリースポーツ)

キンギョのゲノム(全遺伝情報)解読に初めて成功したと、大阪大などのチームが26日付の米科学誌電子版に発表した。ゲノムは生物の設計図ともいわれ、さまざまな形態を持...

  1. 家畜ふん尿:お得に燃料 阪大開発 秋に北...
  2. 科学の森:続く黒潮大蛇行、影響は 12年...
  3. 今どきサイエンス:文化としての科学=鴨志...
  4. 深海アイドル図鑑:/97 宝石サンゴ (...

ニュース一覧

[Edoxaban in patients with atrial fibrillation and cancer].

著者 Maurea N , Riva L
G Ital Cardiol (Rome).2018 Sep ; 19(9):13-19.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (97view , 0users)

Full Text Sources

Miscellaneous

Advances in cancer therapy have led to a significant improvement of survival in most types of malignancies over the past few decades. As a result, there is a growing population of cancer survivors, expected to reach 18 million people in 2030 in the US and a similar number in Europe. Interestingly, cancer survivor studies have shown that although about half of these patients eventually die of cancer, one third of them actually die of cardiovascular disease. Arrhythmias represent a significant part of cardiovascular complications and atrial fibrillation is the main arrhythmia occurring in cancer patients.Antithrombotic therapy is a challenge: the optimal international normalized ratio (INR) level in patients on therapy with vitamin K antagonists is achieved in only 12% of them; in these patients, direct oral anticoagulants seem to be effective and safe for the prevention of stroke and systemic embolic events compared to warfarin and have similar risk of major bleeding. Among the trials, ENGAGE AF-TIMI 48 provides more data on the efficacy and safety of edoxaban in cancer patients.
PMID: 30284558 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード